• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

清醒犬静脉顺应性的记录:一种评估静脉收缩剂的方法。

The recording of venous compliance in the conscious dog: a method for the assessment of venoconstrictor agents.

作者信息

Müller-Schweinitzer E

出版信息

J Pharmacol Methods. 1984 Aug;12(1):53-8. doi: 10.1016/0160-5402(84)90006-8.

DOI:10.1016/0160-5402(84)90006-8
PMID:6536814
Abstract

Determinations of drug-induced changes in venous compliance were performed in conscious dogs using a linear variable differential transformer. Changes in the diameter of the canine saphenous vein, produced by inflation to 45 mmHg of a sphygmomanometer cuff placed on the upper hind leg, were recorded. The cuff was inflated at 5-min intervals for 2 min before and after drug administration. Validation studies of this new method were performed by investigating the venoconstrictor activity of dihydroergotamine (Dihydergot). The intravenous administration of DHE, either locally or systemically, elicited dose-dependent and longlasting venoconstrictor responses with extremely small interindividual variations. Comparison of the present results to those reported for man suggests that recording of venous compliance in the conscious dog provides data with good predictability.

摘要

使用线性可变差动变压器,在清醒犬中测定药物引起的静脉顺应性变化。通过将置于后肢上部的血压计袖带充气至45 mmHg,记录犬隐静脉直径的变化。在给药前后,袖带每隔5分钟充气2分钟。通过研究双氢麦角胺(Dihydergot)的静脉收缩活性,对这种新方法进行了验证研究。局部或全身静脉注射双氢麦角胺均可引起剂量依赖性和持久的静脉收缩反应,个体间差异极小。将目前的结果与报道的人类结果进行比较表明,清醒犬静脉顺应性的记录提供了具有良好可预测性的数据。

相似文献

1
The recording of venous compliance in the conscious dog: a method for the assessment of venoconstrictor agents.清醒犬静脉顺应性的记录:一种评估静脉收缩剂的方法。
J Pharmacol Methods. 1984 Aug;12(1):53-8. doi: 10.1016/0160-5402(84)90006-8.
2
Pharmacodynamics and pharmacokinetics of dihydroergotamine (DHE) in conscious beagle dogs.
Folia Haematol Int Mag Klin Morphol Blutforsch. 1988;115(1-2):162-5.
3
Dihydroergotamine: pharmacokinetics, pharmacodynamics, and mechanism of venoconstrictor action in beagle dogs.
J Cardiovasc Pharmacol. 1987 Jun;9(6):686-93.
4
Venoconstrictor effects of dihydroergotamine after intranasal and intramuscular administration.
Eur J Clin Pharmacol. 1986;30(5):581-4. doi: 10.1007/BF00542418.
5
Recording of the saphenous vein compliance by an ultrasonic echo-tracking device in the dog: effects of S 18149.利用超声回声跟踪装置记录犬隐静脉顺应性:S 18149的作用
Br J Pharmacol. 1997 Dec;122(7):1361-6. doi: 10.1038/sj.bjp.0701526.
6
Ex vivo studies after oral treatment of the beagle with dihydroergotamine.用双氢麦角胺对小猎犬进行口服治疗后的体外研究。
Eur J Pharmacol. 1983 Apr 22;89(1-2):1-8. doi: 10.1016/0014-2999(83)90601-5.
7
Venoconstrictor responses to dihydroergocristine and dihydroergotamine: evidence for the involvement of 5-HT1 like receptors.对双氢麦角环肽和双氢麦角胺的静脉收缩反应:5-羟色胺1样受体参与的证据。
Cardiovasc Drugs Ther. 1990 Dec;4(6):1455-60. doi: 10.1007/BF02026491.
8
Interactions of dihydroergotamine with etilefrine in human leg veins in vitro and in situ.双氢麦角胺与乙苯福林在人体腿部静脉的体外和原位相互作用。
Int J Clin Pharmacol Ther Toxicol. 1987 Feb;25(2):63-9.
9
A new technique for recording compliance of human hand veins.一种记录人体手部静脉顺应性的新技术。
Br J Clin Pharmacol. 1981 Mar;11(3):237-43. doi: 10.1111/j.1365-2125.1981.tb00527.x.
10
Pharmacological actions of the main metabolites of dihydroergotamine.
Eur J Clin Pharmacol. 1984;26(6):699-705. doi: 10.1007/BF00541928.

引用本文的文献

1
Clinical pharmacology, physiology and pathophysiology of superficial veins--2.浅静脉的临床药理学、生理学及病理生理学——2.
Br J Clin Pharmacol. 1994 Oct;38(4):289-305. doi: 10.1111/j.1365-2125.1994.tb04357.x.
2
The effects of nitroglycerin on exercise-induced regional myocardial contractile dysfunction are not diminished by pretreatment with dihydroergotamine.二氢麦角胺预处理不会减弱硝酸甘油对运动诱发的局部心肌收缩功能障碍的作用。
Br J Pharmacol. 1987 Sep;92(1):87-95. doi: 10.1111/j.1476-5381.1987.tb11299.x.
3
Changes in the venous compliance by bradykinin and angiotensin II and its significance for the vascular effects of cyclosporine-A.
缓激肽和血管紧张素II对静脉顺应性的影响及其在环孢素A血管效应中的意义。
Naunyn Schmiedebergs Arch Pharmacol. 1988 Dec;338(6):699-703. doi: 10.1007/BF00165637.
4
Interaction of cyclosporine-A with the renin-angiotensin system in canine veins.环孢素A与犬静脉肾素-血管紧张素系统的相互作用
Naunyn Schmiedebergs Arch Pharmacol. 1989 Aug;340(2):252-7. doi: 10.1007/BF00168977.
5
Venoconstrictor responses to dihydroergocristine and dihydroergotamine: evidence for the involvement of 5-HT1 like receptors.对双氢麦角环肽和双氢麦角胺的静脉收缩反应:5-羟色胺1样受体参与的证据。
Cardiovasc Drugs Ther. 1990 Dec;4(6):1455-60. doi: 10.1007/BF02026491.